[PDF] Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD (2014) by Alexandre Trifilieff

Description

Chronic obstructive pulmonary disease (COPD) is a multi-component condition that results in increasingly limited airflow, usually associated with an abnormal inflammatory response of the lung. It constitutes a major public health burden worldwide, while only very few effective therapies are available.

Reviews